|
|
Fioricet Without a Prescription
Fioricet, also sold under the brand Esgic, is a combined analgesic, containing three active ingredients: acetaminophen, butalbital and caffeine. This medication is used to treat tension headaches. Also, it may be prescribed by your doctor for migraine headaches.
If you need to receive a prescription for Fioricet or Esgic you should be aware of the following information:
- If you have severe breathing problems (e.g., bronchopneumonia), or enzyme disorder called porphyria - Fioricet is not for you and you need to discuss with healthcare provider possible alternative treatments such as NSAIDs, triptans, acupuncture, biofeedback, 5-HTP.
- Fioricet is better than acetaminophen with codeine in the treatment of
chronic recurring tension headache1
- Normal, limited use is usually safe and cost-effective, with
only occasional and mild side effects2
- On the other hand, frequent or prolonged use can lead to drug-induced ("rebound") headaches and tolerance.
Online RX for Fioricet
Health Solutions Network enables US buyers to request Fioricet without prior prescription. They are trustworthy U.S. based service and have been in business for more than 5 years. They will issue an online RX which includes directions on how to use the medication, dosage adjusted for your health condition, and precautions information.
| Dosage |
Quantity |
Pharmacy |
Price |
Shipping |
Buy |
| Fioricet 50/325/40 mg |
30 tablets |
MPLLC.net |
$114 |
$18 |
|
| Fioricet 50/325/40 mg |
60 tablets |
MPLLC.net |
$146 |
$18 |
|
| Fioricet 50/325/40 mg |
90 tablets |
MPLLC.net |
$185 |
$18 |
|
| Generic Fioricet 50/325/40 mg |
30 tablets |
MPLLC.net |
$79 |
$18 |
|
| Generic Fioricet 50/325/40 mg |
60 tablets |
MPLLC.net |
$85 |
$18 |
|
| Generic Fioricet 50/325/40 mg |
90 tablets |
MPLLC.net |
$89 |
$18 |
|
US Pharmacies |
| Health Solutions Network (MPLLC) |
JRB Health Solutions LLC |
MasterCard, Visa, Money Order, E-check |
Visa, Money Order |
FedEx next day delivery
|
UPS next day delivery |
1-888-738-3822 (9am - 6pm PST)
customersupport@healthsol.net |
1-866-966-1452 (9am - 6pm PST)
customerservice@eurexsoftwaresystems.com |
Drug Information
How to take
- Fioricet may cause you to become drowsy or less alert. Driving
or participating in any hazardous activity that requires full
mental alertness is not recommended until you know your response
to the drug.
- Butalbital slows the central nervous system (CNS) and intensifies
the effects of alcohol and other CNS depressants. Concurrent use with alcohol
may also cause overdose symptoms.
- The most frequent side effects are drowsiness, lightheadedness, dizziness, sedation, nausea, vomiting, shortness of breath, and intoxicated feeling.
- Most people taking Fioricet avoid dependency problems. However, mental and physical dependence can occur with the use of this type of analgesics when the medication is used in higher than
recommended doses or over long periods of time.
Dosage
One or two tablets every four hours as needed or as directed by your doctor. Total daily dosage should
not exceed 6 tablets. Extended and repeated use of Fioricet is
not recommended because of the potential for tolerance and dependence.
Don't use butalbital-containing prescription drugs such as Esgic or Fioricet without obvious medical need. Not all headaches require such a powerful medicine.
Fioricet will relieve a headache better if you take it as soon as the headache begins. People suffering from frequent recurring headaches may need a different prescription to help prevent headaches.
References
- 1. Friedman AP, DiSerio FJ. Symptomatic treatment
of chronically recurring tension headache: a placebo-controlled,
multicenter investigation of Fioricet and acetaminophen with codeine.
Clin Ther. 1987;10(1):69-81. PubMed
- 2. Solomon S. Butalbital-containing agents:
should they be banned? No. Curr Pain Headache Rep. 2002 Apr;6(2):147-50.
PubMed
|
Quick facts
- In 2003 Watson Pharmaceuticals, a manufacturer of generic and brand
drugs, acquired the U.S. marketing rights to the Fioricet and
Fiorinal product lines, for $178 million from Novartis.
- The divested products achieved combined sales of approximately
USD 60 million in 2002.
|